Bank Of Montreal Mersana Therapeutics, Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 13, 2024	BUY	$4.0 - $7.02 $82,004 - $143,917	20,501 New	20,501 $84,000
Q4 2022 Feb 01, 2023	BUY	$5.65 - $7.86 $197 - $275	35 Added 0.21%	16,704 $97,000
Q3 2022 Nov 10, 2022	SELL	$4.63 - $8.0 $314 - $544	-68 Reduced 0.41%	16,669 $127,000
Q2 2022 Aug 11, 2022	SELL	$2.84 - $5.0 $3.24 Million - $5.7 Million	-1,140,898 Reduced 98.55%	16,737 $86,000
Q1 2022 May 12, 2022	BUY	$3.74 - $6.63 $4.33 Million - $7.68 Million	1,157,635 New	1,157,635 $4.67 Million

125

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $52.5M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.